Having trouble accessing articles? Reset your cache.

Myrexis preclinical data

In mice bearing nicotinate phosphoribosyltransferase ( NAPRT1)-deficient pancreatic tumors, 75 mg/kg oral

Read the full 124 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE